表紙
市場調查報告書
商品編碼
138630

農業生物科技世界市場

Agricultural Biotechnology

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 211 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告針對世界農業生物科技市場調查、提供農業生物科技重要性與優勢、引進的各種課題與阻礙、法規環境、產品區分 (基因轉殖種子&農作物、生物農藥)、地區/主要國家分類動向與市場規模推算及預測、技術革新和新產品市場投入動向、近年M&A狀況、主要企業檔案。

第1章 介紹、調查方法、產品定義

第2章 摘要整理

  • 產業概要
    • 食品需要量與生產量差距加大:農業生物科技重要性擴大
    • 市場機會的指標
    • 帶動成長的基因轉殖種子&農作物
    • GM農作物的巨大優勢
    • 世界生物科技農地:概要
    • 領導GM農作物栽培的先進國家、實現未來成長的新興國家
    • 生物科技使用擴大的阻礙、其他
  • 競爭環境
    • 環境激烈化
    • 大型收購市場整合
  • 市場課題、市場動向
    • 食品安全保障:市場機會的來源
    • 生物燃料需求擴大:GM農作物市場的正面影響
    • Bt. Cotton、Bt茄子:農產物收穫量擴大
    • IRRI:抗壓性品種開發
    • 耐蟲性農作物開發
    • 生物科技與IT融合
    • 新型除草劑開發:
    • 讓收穫量擴大的先進農業技法
    • 消費者教育、其他
  • 農業生物科技:概要
    • 生物科技機能
    • 農業生物科技概歷
    • 基因開發的重要期間
    • 農業生物科技的優點
    • 簡單促進食品生產
    • 食品品質、營養價值強化
    • 環境上優勢
    • 近代農業除草劑接受度
    • 水質保護
    • 防止生病
    • 營養、品質、健康上優點
    • 各種企業種類
    • R&D企業
    • 產品製造企業
    • 種子企業
    • 醫要品企業
    • 主要終端應用
    • 基因改造農作物
    • 油糧種子開發
    • 課題、影響
    • 消費者相關課題、影響
    • 農業相關課題、影響
    • 環境相關課題、影響、其他
  • 法規環境
    • IP與農業生物科技
    • TRIPS與生物科技
    • 風險評估
    • 歐洲政策
    • 美國政策
    • 標籤與與品牌
  • 產品的加入、創新
  • 近年業界動向
  • 主要世界企業
  • 世界市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
  • 拉丁美洲
  • 其他
目錄
Product Code: MCP-1090

Abstract:

Global Agricultural Biotechnology Market to Reach $66.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Agricultural Biotechnology estimated at US$35.3 Billion in the year 2020, is projected to reach a revised size of US$66.2 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027. Molecular Diagnostics, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$26.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Tissue Culture segment is readjusted to a revised 10.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $10.5 Billion, While China is Forecast to Grow at 8.7% CAGR

The Agricultural Biotechnology market in the U.S. is estimated at US$10.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.4 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.7% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Vaccines Segment to Record 8.5% CAGR

In the global Vaccines segment, USA, Canada, Japan, China and Europe will drive the 8.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.2 Billion in the year 2020 will reach a projected size of US$5.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.6 Billion by the year 2027.

Select Competitors (Total 70 Featured) -

  • ADAMA Agricultural Solutions Ltd.
  • BASF SE
  • Bayer CropScience AG
  • Certis USA LLC
  • Dow AgroSciences LLC
  • DuPont Pioneer
  • Marrone Bio Innovations Inc.
  • Monsanto Company
  • Performance Plants Inc.
  • Syngenta AG
  • Valent BioSciences Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Prelude
    • Recent Market Activity
    • Widening Gap between Food Demand and Production Raises Significance of Agricultural Biotechnology
    • Opportunity Indicators in a Nutshell
    • Transgenic Seeds & Crops Spearhead Growth in the Agricultural Biotech Market
    • Highlights
    • Significant Benefits of GM Crops Augur Well for Market Growth
    • Biotech Cropland Worldwide - An Overview
    • Developed Regions Lead GM Crop Cultivation, Developing Regions Promise Future Growth
    • Barriers to Expansion of Biotechnology in Agriculture Industry
    • Bt. Cotton: Adoption All Set to Increase Further in the Coming Years
    • Robust R&D Pipeline to Play a Pivotal Role in Adoption of Bt. Cotton
    • Challenges Hindering Wider Adoption of GM Crops
    • Biopesticides: Natural Attributes Spur Global Demand
    • Developed Countries: Leading Consumers of Biopesticides
    • Biopesticides - A Crucial Component for Implementing Integrated Pest Management
    • Explosive Growth in Organic Farming Augurs Well for Biopesticides Market
    • Lack of Familiarity & Negative Perceptions Hinder Uptake of Biopesticides among Farmers
    • Biopesticide Regulations in the US and Europe
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • ADAMA Agricultural Solutions Ltd. (Israel)
    • BASF SE (Germany)
    • Bayer CropScience AG (Germany)
    • Certis USA LLC (USA)
    • Dow AgroSciences, LLC (USA)
    • Mycogen Seeds (USA)
    • DuPont Pioneer (USA)
    • Marrone Bio Innovations, Inc. (USA)
    • Monsanto Company (USA)
    • Performance Plants, Inc. (Canada)
    • Syngenta AG (Switzerland)
    • Valent BioSciences Corporation (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Food Security - An Opportunity Generator
    • Rising Demand for Biofuels: Positive Implications for GM Crops Market
    • Introduction of Bt Cotton and Bt Brinjal Enhance Agricultural Production
    • IRRI Working to Develop Stress-Tolerant Rice Variants
    • Advent of Insect Resistant Crops Fuel Growth for Agriculture Industry
    • Global Reservations Persist in Acknowledging Benefits of GM Crops
    • Integration of Biotechnology and IT Revolutionizes Agriculture Sector
    • Development of New Herbicide-Tolerant Traits Gathers Steam
    • Advanced Farming Techniques for Increasing Agricultural Yields
    • Misuse of Indigenous Resources of Developing Countries: A Cause of Concern
    • Educating Consumers - Need of the Hour
    • Synthetic Biology - A Brief Review
    • Synthetic Biology: Prediction Becoming Reality
    • Biostimulants: Growing Interest in Organic Food to Propel Growth
    • Need for Sustainable Agriculture - Key Growth Driver
    • Lack of Thorough Research Impedes Growth in Biostimulants Market
    • Need for Paradigm Shift in Grower Mindset Regarding Biostimulants
    • The Road Ahead
    • Sales of Non-GMO products to Register Impressive Growth
    • Public-Private Sector Partnerships Gain Importance
    • Protection of Intellectual Property Demands High Attention
    • Challenges Aplenty for Agricultural Biotechnology in Developing Nations
    • Dearth of Competent Leadership
    • Insufficient Financial Support for R&D
    • Lack of Scientific and Technological Infrastructure
    • Insufficient Expertise and Human Resources
    • Safety Issues
    • Ethical Issues
    • Lack of Regulatory Framework
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Tissue Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Synthetic Biology-enabled Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 40: Japan Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 43: Japan Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 46: China Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 49: China Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 52: Europe Current & Future Analysis for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 61: France Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 64: France Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 67: Germany Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 70: Germany Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 73: Italy Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 76: Italy Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 79: UK Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 82: UK Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 88: Rest of Europe Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of Europe 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 91: Asia-Pacific Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 94: Asia-Pacific Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Asia-Pacific Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Asia-Pacific 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 97: Rest of World Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
    • TABLE 100: Rest of World Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of World Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of World 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 70